Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

VTOL vs SRTA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VTOL Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

VTOL Overall Winner 6-Pillar Tally: VTOL 4 – 2 SRTA Matrix Metrics: VTOL 8 – 2 SRTA

As of Nov 17, 2026, Bristow Group Inc. (VTOL) is the stronger overall head-to-head candidate over Strata Critical Medical, Inc. (SRTA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VTOL carries a Unified Composite Score of 46.7/100 (HOLD) at $39.27 (8.8x Forward P/E, 10.6% operating margin), whereas SRTA carries 32.7/100 (SELL) at $5.26 (69.9x Forward P/E, -4.7% operating margin).

  • Growth vs. Quality Trade-Off: VTOL earns the overall head-to-head edge with a stronger Unified Composite Score (46.7/100 HOLD vs. SRTA 32.7/100 SELL) and 0.48β · 43% Vol risk profile, whereas SRTA leads top-line expansion (+50.3% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: VTOL is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.2); meanwhile SRTA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VTOL vs SRTA
VTOL NYSE Head-to-Head Winner
Bristow Group Inc.
Air Transportation, Nonscheduled
$39.27
-0.81% 1D
Market Cap $1.2B
TTM Revenue $1.62B
Forward P/E 8.8x
Beta / 30D Vol 0.48β · 43% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 45.0 Fund 51.0 Flow 57.0 Mom 58.9
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -5.1%) with fading momentum, RSI 47
RSI-14: 47.2 · SMA20: $39.92 · SMA50: $40.60
SRTA NASDAQ
Strata Critical Medical, Inc. Class A Common Stock
Air Transportation, Nonscheduled
$5.26
-2.95% 1D
Market Cap $492.2M
TTM Revenue $281M
Forward P/E 69.9x
Beta / 30D Vol 1.95β · 80% Vol
Unified Composite Score
32.7 / 100 SELL
Tech 8.0 Fund 35.0 Flow 57.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.1 · SMA20: $5.12 · SMA50: $5.02

6-Pillar Scorecard Institutional Category Breakdown (VTOL 4 – 2 SRTA)

Columns: Metric · VTOL · SRTA
1. Valuation Multiples VTOL
Forward P/E 8.8x 69.9x
Trailing P/E 15.0x 138.9x
PEG Ratio N/M N/M
EV / Revenue 1.2x 1.6x
2. Growth & Scale SRTA
Revenue Growth (YoY) +13.4% +50.3%
Earnings Growth (YoY) -45.9% +0.0%
TTM Revenue (USD) $1.62B $281M
Market Cap $1.2B $492.2M
3. Profitability & Quality VTOL
Gross Margin 27.8% 21.6%
Operating Margin 10.6% -4.7%
Net Profit Margin 5.0% -8.8%
Return on Equity (ROE) 7.6% -7.5%
4. Balance Sheet & Cash Flow VTOL
Cash Generation (TTM) $12M -$382,000
Cash Flow Margin 0.8% -0.1%
Net Cash / Leverage $742M Net Debt (0.89x D/E) $32M Net Cash
Dividend Yield 0.92% None (0.00%)
5. Options & Positioning VTOL
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 154.9% (23rd %ile) 61.9% (8th %ile)
Put/Call OI Skew 0.02x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Distribution DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat SRTA
OpEx & R&D Intensity 17.2% of Rev ($278M) 26.3% of Rev ($74M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas Equipment & Services Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VTOL (8) vs SRTA (2)
Institutional Metric VTOL SRTA Criterion Row Edge
Market Capitalization
Scale
$1.2B $492.2M Larger Scale VTOL
Trailing P/E Ratio
Valuation
15.0x 138.9x Lower Multiple VTOL
Forward P/E Ratio
Valuation
8.8x 69.9x Lower Multiple VTOL
Revenue Growth (YoY)
Growth
+13.4% +50.3% Higher Growth SRTA
Operating Margin (TTM)
Profitability
10.6% -4.7% Higher Margin VTOL
Net Profit Margin
Profitability
5.0% -8.8% Higher Margin VTOL
Return on Equity (ROE)
Capital Efficiency
7.6% -7.5% Higher ROE VTOL
52-Week Range Position
Momentum
25% ($36–$50) 51% ($4–$6) Stronger Trend SRTA
Beta / 30D Volatility
Risk Regime
0.48β · 43% Vol 1.95β · 80% Vol Lower Realized Risk VTOL
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 32.7 / 100 (SELL) Higher Composite VTOL
Trailing 12M Revenue (USD)
Operating Scale
$1.62B $281M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
27.8% 21.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.2x EV/Rev N/M PEG · 1.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$12M ($742M Net Debt (0.89x D/E)) -$382,000 ($32M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SRTA +14.12 pp
VTOL: +1.74% · SRTA: +15.86%
3M Horizon SRTA +5.23 pp
VTOL: -15.93% · SRTA: -10.7%
6M Horizon SRTA +7.27 pp
VTOL: -6.5% · SRTA: +0.77%
1Y Horizon SRTA +8.7 pp
VTOL: +1.11% · SRTA: +9.81%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VTOL Revenue SRTA Revenue VTOL Op. Margin SRTA Op. Margin Margin Leader
FY2018 $220M N/A 12.7% N/A VTOL
FY2019 $230M $30M -1.5% -37.0% VTOL
FY2020 N/A $20M N/A -44.2% SRTA
FY2021 $1.14B $50M -4.9% -47.7% VTOL
FY2022 $1.21B $150M 0.8% -36.6% VTOL
FY2023 $1.26B $230M 4.8% -30.3% VTOL
FY2024 $1.42B $150M 9.4% -15.3% VTOL
FY2025 $1.49B $200M 10.7% -11.3% VTOL

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VTOL CONSOLIDATION
74d in phase · OBV ACCUMULATION
Current IV 154.9%
IV Percentile 23rd %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact VTOL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SRTA CONSOLIDATION
120d in phase · OBV DISTRIBUTION
Current IV 61.9%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact SRTA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VTOL Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas Equipment & Services Operator
Competes within the Oil & Gas Equipment & Services value chain with $1.2B market capitalization and 10.6% operating margin.
OpEx & R&D Reinvestment 17.2% of Rev ($278M)
90D Engineering Disclosures 0 Published
SRTA Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $492.2M market capitalization and -4.7% operating margin.
OpEx & R&D Reinvestment 26.3% of Rev ($74M)
90D Engineering Disclosures 0 Published

Investor FAQ VTOL vs SRTA Key Questions & Quantitative Answers

As of Nov 17, 2026, Bristow Group Inc. (VTOL) is the stronger overall head-to-head candidate over Strata Critical Medical, Inc. (SRTA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VTOL carries a Unified Composite Score of 46.7/100 (HOLD) at $39.27 (8.8x Forward P/E, 10.6% operating margin), whereas SRTA carries 32.7/100 (SELL) at $5.26 (69.9x Forward P/E, -4.7% operating margin). Growth vs. Quality Trade-Off: VTOL earns the overall head-to-head edge with a stronger Unified Composite Score (46.7/100 HOLD vs. SRTA 32.7/100 SELL) and 0.48β · 43% Vol risk profile, whereas SRTA leads top-line expansion (+50.3% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: VTOL is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.2); meanwhile SRTA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SRTA leads the Growth & Scale pillar: VTOL posts +13.4% YoY revenue growth and -45.9% YoY earnings growth on $1.62B TTM revenue (27.8% gross margin, 10.6% operating margin), compared with SRTA at +50.3% YoY revenue growth and +0.0% YoY earnings growth on $281M TTM revenue (21.6% gross margin, -4.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), VTOL cumulative revenue shifted +577.3% while SRTA shifted +566.7%. In operating R&D and SG&A reinvestment, VTOL deploys 17.2% of Rev ($278M) (0 90-day corporate R&D disclosures) versus 26.3% of Rev ($74M) (0 disclosures) for SRTA.

VTOL screens cheaper on headline valuation multiples. VTOL trades at 8.8x Forward P/E, 15.0x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (0.8% FCF margin), whereas SRTA trades at 69.9x Forward P/E, 138.9x Trailing P/E, N/M PEG, and 1.6x EV/Revenue (-0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VTOL (7.6% ROE) versus SRTA (-7.5% ROE) capital efficiency.

In options market volatility and institutional positioning, VTOL carries 154.9% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.48β · 43% Vol realized risk). By comparison, SRTA carries 61.9% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.95β · 80% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.